Related Drugs: Entresto
Sacubitril/valsartan is prescribed to reduce the risk of heart-related death and hospitalization for adults with heart failure. It is also used to treat heart failure symptoms in children who are at least one year old.
In general, the names and strengths of drugs can vary globally due to differing marketing strategies. This is the case with sacubitril/valsartan (brand names: Entresto, Vymada, CIDMUS, Oneptus, Azmarda, Neparvis, Sacurise). Any variations need to be approved by your prescriber.
Novartis markets sacubitril/valsartan under the name Entresto in the United States, UK, and Canada with the strengths 24/26 mg, 49/51 mg, and 97/103 mg.
Novartis markets sacubitril/valsartan in India and South Africa under the name Vymada with strengths 50mg, 100mg, and 200mg.
Dr. Reddy’s markets sacubitril/valsartan in India under the name CIDMUS with the strengths 50mg, 100mg, and 200mg. Cipla also markets sacubitril/valsartan under those same strengths in India. Sun Pharma markets it under the name Sacurise with those same strengths.
Novartis markets sacubitril/valsartan in Turkey under the name Oneptus with strengths of 24/26 mg, 49/51 mg, and 97/103 mg.
PharmacyChecker has also seen sacubitril/valsartan sold under the brand names Azmarda (in India) and Neparvis (in Europe).
As of July 2024, the FDA has approved a handful of generic versions for Entresto. However, these generics may not be available at U.S. pharmacies until the following year, when one of the Novartis patents expires in July 2025. Americans can save money on Entresto by comparing prices at international online pharmacies with discount prices available at U.S. pharmacies. Accredited international online pharmacies may carry alternative brand names.
Entresto sold in the U.S. is manufactured by Novartis in Singapore. Entresto Sprinkle sold in the U.S. is manufactured by Novartis in Slovenia.
International Online Pharmacies Offer Relief as Medicare Prices Remain Sky-High - December 9, 2024
Another missed opportunity for the U.S. government to do right by patients struggling to afford medicines.
Read MoreHow to Pay Less for Entresto: Medicare, Coupons, and International Options - August 27, 2024
...This is the case with sacubitril/valsartan (brand names: Entresto, Vymada, CIDMUS, Oneptus, Azmarda, Neparvis, Sacurise). Any variations need to be approved by your prescriber. Novartis markets sacubitril/valsartan under the name Entresto in the United States, UK, and Canada with the strengths 24/26 mg, 49/51 mg, and 97/103 mg.
Read MoreMedicare Negotiated Drug Prices 4.7 Times Higher Than NHS Negotiated Prices - August 22, 2024
The Health and Human Services (HHS) Secretary, once forbidden by law to negotiate drug prices covered by Medicare, has just established the maximum fair price it will pay for ten drugs in 2026. According to the Inflation Reduction Act, selected drugs for negotiation had to fit a certain market profile.
Read MoreInternational Online Pharmacies Offer Relief as Medicare Prices Remain Sky-High - December 9, 2024
Another missed opportunity for the U.S. government to do right by patients struggling to afford medicines.
How to Pay Less for Entresto: Medicare, Coupons, and International Options - August 27, 2024
Patients prescribed patented, brand-name medicines that have yet to face competition from generic drugmakers are too often subjected to unimaginably high prescription drug bills. The result is a hunt for ways to save, be it through patient assistance programs, pharmacy discount coupons, or international mail order. Such is the case for those prescribed the heart failure drug Entresto.
Medicare Negotiated Drug Prices 4.7 Times Higher Than NHS Negotiated Prices - August 22, 2024
The Health and Human Services (HHS) Secretary, once forbidden by law to negotiate drug prices covered by Medicare, has just established the maximum fair price it will pay for ten drugs in 2026. According to the Inflation Reduction Act, selected drugs for negotiation had to fit a certain market profile.
PharmacyChecker Recognized by JAMA as Key Resource for Finding Reputable Online Pharmacies - October 21, 2024
White Plains, New York – October 21, 2024 – PharmacyChecker, a trusted platform for verifying international online pharmacies and comparing prescription drug prices, has been recognized in a recent Journal of the American Medical Association (JAMA) article as a valuable resource "to find a reputable online pharmacy that can supply high-quality prescription drugs." Authored by healthcare professionals from Brigham and Women’s Hospital and Harvard Medical School, the article “Strategies to Help Patients Navigate High Prescription Drug Costs” acknowledges the role of international online pharmacies and PharmacyChecker in helping patients manage high prescription drug costs in the United States.
PharmacyChecker Announces Ross Phan as Director of Pharmacy Verification and Information - April 22, 2024
White Plains, NY – April 22, 2024 – PharmacyChecker.com announces today that the company has hired Ross Phan, PharmD, MBA, BCACP, BCGP, BCPS as Director of Pharmacy Verification & Information. Dr.
PharmacyChecker Statement on Federal Court’s Denial of LegitScript’s Motion to Block Antitrust Lawsuit - January 8, 2024
White Plains, New York – January 8th, 2024 – In response to U.S. District Judge Michael H.
PharmacyChecker Introduces List of Trusted Telemedicine Providers - June 20, 2023
White Plains, New York – June 20th, 2023 – PharmacyChecker, a company known for its international online pharmacy verification program and drug price comparisons, is pleased to announce the launch of its list of trusted telemedicine providers.
Sacubitril/valsartan is prescribed to reduce the risk of heart-related death and hospitalization for adults with heart failure. It is also used to treat heart failure symptoms in children who are at least one year old.
In general, the names and strengths of drugs can vary globally due to differing marketing strategies.
Novartis markets sacubitril/valsartan under the name Entresto in the United States, UK, and Canada with the strengths 24/26 mg, 49/51 mg, and 97/103 mg.
Novartis markets sacubitril/valsartan in India and South Africa under the name Vymada with strengths 50mg, 100mg, and 200mg.
Dr. Reddy’s markets sacubitril/valsartan in India under the name CIDMUS with the strengths 50mg, 100mg, and 200mg. Cipla also markets sacubitril/valsartan under those same strengths in India. Sun Pharma markets it under the name Sacurise with those same strengths.
Novartis markets sacubitril/valsartan in Turkey under the name Oneptus with strengths of 24/26 mg, 49/51 mg, and 97/103 mg.
PharmacyChecker has also seen sacubitril/valsartan sold under the brand names Azmarda (in India) and Neparvis (in Europe).
As of July 2024, the FDA has approved a handful of generic versions for Entresto. However, these generics may not be available at U.S. pharmacies until the following year, when one of the Novartis patents expires in July 2025. Americans can save money on Entresto by comparing prices at international online pharmacies with discount prices available at U.S. pharmacies. Accredited international online pharmacies may carry alternative brand names.
Entresto sold in the U.S. is manufactured by Novartis in Singapore. Entresto Sprinkle sold in the U.S. is manufactured by Novartis in Slovenia.
*The total price listed on PharmacyChecker.com includes the accredited pharmacy’s shipping fee, which typically covers an entire order. Patients and caregivers may find it more cost-effective to purchase multiple medications in a single order.
Laws affecting the importation of medication for personal use are different from country to country. For instance, personal drug importation is expressly legal in Australia. In the United States, technically, it is illegal to import unapproved medication under most circumstances, whether through purchase over the Internet or while on a trip to a foreign country. U.S. government officials have stated that individuals who order non-controlled prescription drugs from foreign sources (up to a three-month supply) for their own use are not being pursued or prosecuted. The U.S FDA regulates the safety and efficacy of medications sold in U.S. pharmacies. Medications dispensed from outside the U.S. are regulated for safety and efficacy by pharmaceutical/pharmacy regulatory authorities in their respective countries. Read about Advanced Pharmaceutical Regulatory Systems.
PharmacyChecker provides free monthly email updates of the latest prices.
icon means that this online pharmacy only ships from dispensing pharmacies located in Canada. Separately, the Tier 1 icon means that an online pharmacy accredited by PharmacyChecker only fills prescription orders through their own pharmacy or dispensing pharmacy partners in Australia, Canada, Israel, New Zealand, United Kingdom, or the U.S. Such countries are known to have equally advanced pharmaceutical and pharmacy regulatory systems. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.
icon means that this online pharmacy accredited by PharmacyChecker fills prescription orders through either their own pharmacy or dispensing pharmacy partners located in Australia, India, Mauritius, New Zealand, Turkey, the UK, or Canada. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.